1. Home
  2. RCEL vs SPE Comparison

RCEL vs SPE Comparison

Compare RCEL & SPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • SPE
  • Stock Information
  • Founded
  • RCEL N/A
  • SPE 1993
  • Country
  • RCEL United States
  • SPE United States
  • Employees
  • RCEL N/A
  • SPE N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • SPE Finance/Investors Services
  • Sector
  • RCEL Health Care
  • SPE Finance
  • Exchange
  • RCEL Nasdaq
  • SPE Nasdaq
  • Market Cap
  • RCEL 161.5M
  • SPE 161.1M
  • IPO Year
  • RCEL N/A
  • SPE N/A
  • Fundamental
  • Price
  • RCEL $5.19
  • SPE $14.95
  • Analyst Decision
  • RCEL Strong Buy
  • SPE
  • Analyst Count
  • RCEL 4
  • SPE 0
  • Target Price
  • RCEL $16.50
  • SPE N/A
  • AVG Volume (30 Days)
  • RCEL 287.8K
  • SPE 25.4K
  • Earning Date
  • RCEL 08-07-2025
  • SPE 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • SPE 8.55%
  • EPS Growth
  • RCEL N/A
  • SPE N/A
  • EPS
  • RCEL N/A
  • SPE N/A
  • Revenue
  • RCEL $71,661,000.00
  • SPE N/A
  • Revenue This Year
  • RCEL $57.29
  • SPE N/A
  • Revenue Next Year
  • RCEL $28.07
  • SPE N/A
  • P/E Ratio
  • RCEL N/A
  • SPE N/A
  • Revenue Growth
  • RCEL 41.35
  • SPE N/A
  • 52 Week Low
  • RCEL $5.10
  • SPE $10.26
  • 52 Week High
  • RCEL $14.16
  • SPE $12.59
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 29.07
  • SPE 50.38
  • Support Level
  • RCEL $5.10
  • SPE $15.00
  • Resistance Level
  • RCEL $6.33
  • SPE $15.29
  • Average True Range (ATR)
  • RCEL 0.32
  • SPE 0.12
  • MACD
  • RCEL 0.02
  • SPE -0.03
  • Stochastic Oscillator
  • RCEL 6.10
  • SPE 25.94

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

Share on Social Networks: